Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque Psoriasis Read more about Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque Psoriasis
FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer Read more about FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Amgen To Present At Guggenheim Healthcare Talks Oncology Day Read more about Amgen To Present At Guggenheim Healthcare Talks Oncology Day
Amgen Sponsors Golden Ticket at BioLabs LA at The Lundquist Institute to Help Accelerate Life Science Startups Read more about Amgen Sponsors Golden Ticket at BioLabs LA at The Lundquist Institute to Help Accelerate Life Science Startups
Amgen Reports Fourth Quarter And Full Year 2020 Financial Results Read more about Amgen Reports Fourth Quarter And Full Year 2020 Financial Results
Amgen Announces Breakthrough Therapy Designation Granted For Sotorasib In China Read more about Amgen Announces Breakthrough Therapy Designation Granted For Sotorasib In China
Amgen Announces Webcast Of 2020 Fourth Quarter And Full Year Financial Results Read more about Amgen Announces Webcast Of 2020 Fourth Quarter And Full Year Financial Results
Amgen's Investigational KRAS G12C Inhibitor Sotorasib Demonstrated Rapid, Deep And Durable Responses In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer Read more about Amgen's Investigational KRAS G12C Inhibitor Sotorasib Demonstrated Rapid, Deep And Durable Responses In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Amgen To Webcast Investor Meeting At 2020 World Conference on Lung Cancer Read more about Amgen To Webcast Investor Meeting At 2020 World Conference on Lung Cancer
Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020 Read more about Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020
